The year in cardiovascular medicine 2021

Michael Aschermann

Cor Vasa 2022, 64(Suppl. 4):5-6 | DOI: 10.33678/cor.2022.134  

Editorial ke článku “The year in cardiovascular medicine 2021: heart failure and cardiomyopathies”

Filip Málek

Cor Vasa 2022, 64(Suppl. 4):58 | DOI: 10.33678/cor.2022.075  

Rok 2021 byl z pohledu srdečního selhání a kardiomyopatií rokem velmi významným. Byla zveřejněna nová definice a klasifikace srdečního selhání a publikace nových Doporučení pro diagnostiku a léčbu srdečního selhání Evropské kardiologické společnosti 2021.

The year in cardiovascular medicine 2021: digital health and innovation

Panos E. Vardas, Folkert W. Asselbergs, Maarten van Smeden, Paul Friedman

Cor Vasa 2022, 64(Suppl. 4):7-17  

Received Date: 13 October 2021; Revision received Date: 15 November 2021; Accepted Date: 23 November 2021 Reproduced from: Vardas PE, Asselbergs FW, van Smeden M, Friedman P. The year in cardiovascular medicine 2021: digital health and innovation. Eur Heart J 2022;43:271–279. https://doi.org/10.1093/eurheartj/ehab874, by permission of Oxford University Press on behalf of the European Society of CardiologyThis article presents some of the most important developments in the fi eld of digital medicine that have appeared over the last 12 months and are related to cardiovascular medicine. The article consists...

The year in cardiovascular medicine 2021: dyslipidaemia

Lale Tokgozoglu, Carl Orringer, Henry N. Ginsberg, Alberico L. Catapano

Cor Vasa 2022, 64(Suppl. 4):18-30  

Received Date: 02 October 2021; Accepted Date: 16 November 2021Reproduced from: Tokgozoglu L, Orringer C, Ginsberg HN, Catapano AL. The year in cardiovascular medicine 2021: dyslipidaemia. Eur Heart J 2022;43:807–817. https://doi.org/10.1093/eurheartj/ehab875, by permission of Oxford University Press on behalf of the European Society of CardiologyThe past year was an exciting time for clinical lipidology when we learnt more about existing therapies as well as therapies targeting novel pathways discovered through genetic studies. LDL cholesterol remained the main target and a variety of drugs to lower...

The year in cardiovascular medicine 2021: diabetes and metabolic disorders

Francesco Cosentino, Deepak L. Bhatt, Nikolaus Marx, Subodh Verma

Cor Vasa 2022, 64(Suppl. 4):31-38  

Received Date: 04 November 2021; Accepted Date: 13 December 2021Reproduced from: Cosentino F, Bhatt DL, Marx N, Verma S. The year in cardiovascular medicine 2021: diabetes and metabolic disorders. Eur Heart J 2022;43:263–270. https://doi.org/10.1093/eurheartj/ehab876, by permission of Oxford University Press on behalf of the European Society of CardiologyIn the current paper, we review recently published studies that are helping us to understand how the treatment landscape for glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter 2 inhibitors is moving forward. We have also included relevant...

The year in cardiovascular medicine 2021: interventional cardiology

Javier Escaned, Farouc A. Jaffer, Julinda Mehilli, Roxana Mehran

Cor Vasa 2022, 64(Suppl. 4):39-47  

Received Date: 28 November 2021; Revision received Date: 09 December 2021; Accepted Date: 13 December 2021Reproduced from: Escaned J, Jaffer FA, Mehilli J, Mehran R. The year in cardiovascular medicine 2021: interventional cardiology. Eur Heart J 2022;43:377–386. https://doi.org/10.1093/eurheartj/ehab884, by permission of Oxford University Press on behalf of the European Society of CardiologySince last year’s report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst...

The year in cardiovascular medicine 2021: valvular heart disease

Helmut Baumgartner, Bernard Iung, David Messika-Zeitoun, Catherine M. Otto

Cor Vasa 2022, 64(Suppl. 4):48-57  

Received Date: 15 September 2021; Revision received Date: 15 October 2021; Accepted Date: 23 December 2021Reproduced from: Baumgartner H, Iung B, Messika-Zeitoun D, Otto CM. The year in cardiovascular medicine 2021: valvular heart disease. Eur Heart J 2022;43:633–640, https://doi.org/10.1093/eurheartj/ehab885, by permission of Oxford University Press on behalf of the European Society of Cardiology.

The year in cardiovascular medicine 2021: heart failure and cardiomyopathies

Johann Bauersachs, Rudolf A. de Boer, Joann Lindenfeld, Biykem Bozkurt

Cor Vasa 2022, 64(Suppl. 4):59-71  

Received Date: 16 September 2021; Revision received Date: 27 October 2021; Accepted Date: 16 November 2021Reproduced from: Bauersachs J, de Boer RA, Lindenfeld J, Bozkurt B. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J 2022;43:367–376. https://doi.org/10.1093/eurheartj/ehab887, by permission of Oxford University Press on behalf of the European Society of CardiologyIn the year 2021, the universal defi nition and classifi cation of heart failure (HF) was published that defi nes HF as a clinical syndrome with symptoms and/or signs caused by a cardiac abnormality...

The year in cardiovascular medicine 2021: cardio-oncology

Joerg Teresa Alexander R.

Cor Vasa 2022, 64(Suppl. 4):72-78  

Received Date: 06 December 2021; Accepted Date: 16 December 2021; Publication date (electronic): 21 December 2021Reproduced from: Herrmann J, López-Fernández T, Lyon AR. The year in cardiovascular medicine 2020: cardio-oncology. Eur Heart J. 2022 Jan 3;ehab891. https://doi.org/10.1093/eurheartj/ehab891, by permission of Oxford University Press on behalf of the European Society of Cardiology

The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease

Susanna Price, Jason Katz, Christoph C. Kaufmann, Kurt Huber

Cor Vasa 2022, 64(Suppl. 4):79-86  

Received 15 December 2021; accepted 23 December 2021; online publish-ahead-of-print 3 January 2022Reproduced from: Price S, Katz J, Kaufmann CC, Huber K. The year in cardiovascular medicine 2020: arrhythmias. Eur Heart J. 2022;43:800–806. https://doi.org/10.1093/eurheartj/ehab908, by permission of Oxford University Press on behalf of the European Society of Cardiology

The year in cardiovascular medicine 2021: imaging

Chiara Nina Marcelo Edward

Cor Vasa 2022, 64(Suppl. 4):87-95  

Received Date: 16 December 2021; Revision received Date: 02 January 2022; Accepted Date: 01 March 2022Reproduced from: Bucciarelli-Ducci C, Ajmone-Marsan N, Di Carli M, Nicol E. The year in cardiovascular medicine 2021: imaging. Eur Heart Journal (2022) 43, 1288–1295. https://doi.org/10.1093/eurheartj/ehac033, by permission of Oxford University Press on behalf of the European Society of CardiologyThis article reviews the most relevant literature published in 2021 on the role of cardiovascular imaging in cardiovascular medicine. Coronavirus disease 2019 (COVID-19) continued to impact the healthcare...

The year in cardiovascular medicine 2021: arrhythmias

Harry J.G.M. Crijns, Prashantan Sanders, Christine M. Albert, Pier D. Lambiase

Cor Vasa 2022, 64(Suppl. 4):96-102  

Received Date: 09 December 2021; Revision received Date: 22 December 2021; Accepted Date: 06 January 2022; Publicationdate (electronic): 08 January 2022Reproduced from: Crijns HJGM, Sanders P, Albert CM, Lambiase PD. The year in cardiovascular medicine 2021: arrhythmias. Eur Heart J 2022;43:1191–1197, https://doi.org/10.1093/eurheartj/ehac007, by permission of Oxford University Press on behalf of the European Society of Cardiology